Screening of phyto-constituents of West Bengal Amla (Phyllanthus emblica L.) : A Comparative enumeration
Abstract
The phyto-constituents present in fruit of Phyllanthus emblica L. (Phyllanthaceae) consumed by the tribal people of West Bengal for the treatment of various disease ailments. Phyllanthus emblica L., a deciduous tree of small to medium size up to 5.5 meters representing a large group of phyto-chemical reservoir of medicinal uses in different disease like diabetes, liver disorder, snake venom neutralizer, diarrhoea, indigestion, anti-tumor, anti-carcinogenic, anti-ulcer, antioxidant, anti-inflammatory activities etc. supporting its ethnicity for the traditional healers. Quantitative estimation of various bioactive constituents reveals the presence of tannins, carbohydrates, acidic compounds, poly phenols, vitamin C, etc. in different proportions. Hence the present investigation was conducted to compare the phyto-constituents of Amla collected from two different regions of West Bengal (one at low land and other at relatively high altitude). The investigation reveals the presence of larger ascorbic acid content West Midnapore region than North Bengal, whereas tannin content is higher in North Bengal. Total poly-phenolic compounds are higher in Jhargram region than that of North Bengal. Hence it can be concluded that climatic and soil composition differences can also play a major role in quantitative changes in phytoconstituents.
References
Anila, L. and Vijayalakshmi, N.R. (2002). Flavonoids from Emblica officinalis and Mangifera indica effectiveness for dyslipidemia. J. Ethnopharmacol. 79(1): 81-87.
Bhattacharya, A., Kumar, M., Ghosal, S. and Bhattacharya, S.K. (2000). Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats. Phytomedicine. 7(2): 173-175.
Bigoniya, P. (2013). Adverse effect of Herbal Medicines: Myth versus. VRI Phytomedicine. 1(1): 1-2.
Krnaveni, M. and Mirunalini, S. (2010). Therapeutic Potential of Phyllanthus emblica (amla): the Ayurvedic Wonder. J. Basic Clin. Physiol. Pharmacol. 21(1): 93 - 105.
Mehta, S., Singh, R. K., Jaiswal, D., Rai, P.K. and Watal, G. (2009). Anti diabetic activity of Emblica officinalis in animal model. Int. J. Pharmacognosy. 47(6) : 1050 – 1055.
Mohamed, I., Shuid, A., Borhanuddin, B. and Fozi, N. (2012). The Application of Phytomedicine in Modern Drug Development. Internet J. Herbal and Plant Med. Pp.1.
Nadkarni, K. M. and Nadkarni, A.K. (1999). Indian Materia medica with Ayurvedic, Unani-Tibbi, Siddha, Allopathic, Homeopathic, Naturopathic and Home remedies. Vol.1. Popular Prakashan Private Ltd., Bombay, India. ISBN No. 81-7154-142-9.
Patel, S.S. and Goyal, R.K. (2012). Emblica officinalis Geart.: A Comprehensive Review on Phytochemistry, Pharmacology and Ethnomedicinal Uses. Res. J. Med. Plant. 6: 06 - 16.
Sachan, K. N., Sudhir, S. G. R., Sharma, R. and Kumar, Y. (2013). An Investigation into phytochemical profile and nutraceutical value of Amla (Emblica officinales) fruits. Int. J. Mod. Pharm. Res. 2 (1): 13.
Sancheti, G., Jindal, A., Kumari, R. and Goyal, P. K. (2005). Chemo-preventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac. J. Cancer Prev. 6(2): 197-201.
Singh, E., Sharma, S., Pareek, A., Dwivedi, J., Yadav, S. and Sharma, S. (2011). Phytochemistry, traditional uses and cancer chemo-preventive activity of Amla (Phyllanthus emblica): The Sustainer. J. Appl. Pharma. Sci. 2 (01): 176-183.
